
Working on a nanotech defense against blindness from glaucoma. #VisiPlate š«
Redwood City, CA
Joined June 2019
- Tweets470
- Following565
- Followers299
- Likes526
Pinned Tweet
Sharing strong 1-year safety and efficacy results from the #VITA trial of #VisiPlate aqueous shunt for open angle #glaucoma: morningstar.com/news/pr-newsā¦
Avisi retweeted
Itās spooky season, and nothing is scarier than ocular issues! Keep your eyes safer this Halloween by following the 5 tips below.
Itās spooky season, and nothing is scarier than ocular issues! Keep your eyes safer this Halloween by following the 5 tips below.
Avisiās Scientific Advisor Dr. Jonathan S. Myers will be presenting the VITA Trial 2-Year outcomes of VisiPlateĀ® Aqueous Shunt on Oct. 10th from 2-3 PM CST at the American Academy of Ophthalmology Annual Meeting (booth #1255).
Avisi retweeted
Avisiās Scientific Advisor Dr. Jonathan S. Myers will be presenting the VITA Trial 2-Year outcomes of VisiPlateĀ® Aqueous Shunt on Oct. 10th from 2-3 PM CST at the American Academy of Ophthalmology Annual Meeting (booth #1255).
This year at the American Academy of Ophthalmology Annual Meeting, Avisi will be hosting the panel presentation, āVisiPlateĀ® Design & Surgical Pearls,ā with Scientific Advisors Dr. Eydie Miller-Ellis and Dr. Joseph Panarelli, moderated by...
Avisi retweeted
This year at the American Academy of Ophthalmology Annual Meeting, Avisi will be hosting the panel presentation, āVisiPlateĀ® Design & Surgical Pearls,ā with Scientific Advisors Dr. Eydie Miller-Ellis and Dr. Joseph Panarelli, moderated by...
Avisi retweeted
to be presented at American Academy of Ophthalmology Annual Meeting in New Orleans, LA, USA. The abstract will be presented at the podium poster theater from 3:30 PM - 4:30 PM CST on October 11, 2026.
Avisi retweeted
Congratulations to Dr. Jonathan S. Myers Avisi Scientific Advisor and Chief of Glaucoma Service at Wills Eye Hospital, for his accepted abstract, āLong-Term Efficacy and Safety of a Novel, Ultrathin, Multichannel Aqueous Shunt in Patients With OAG,ā ...
Congratulations to Dr. Jonathan S. Myers Avisi Scientific Advisor and Chief of Glaucoma Service at Wills Eye Hospital, for his accepted abstract, āLong-Term Efficacy and Safety of a Novel, Ultrathin, Multichannel Aqueous Shunt in Patients With OAG,ā ...
Avisi retweeted
BREAKING NEWS! Avisi Technologies will be presenting VisiPlateĀ® 2-year Data at the American Academy of Ophthalmology Annual Meeting in New Orleans, Louisiana, on October 10th, 2026.
BREAKING NEWS! Avisi Technologies will be presenting VisiPlateĀ® 2-year Data at the American Academy of Ophthalmology Annual Meeting in New Orleans, Louisiana, on October 10th, 2026.
View the full press release: tinyurl.com/cmcv7uzj To learn more about Avisi Technologies or VisiPlateĀ®, a next-generation treatment for glaucoma, visit avisitech.com.
Visit Avisiās booth #1255 for presentations starting at 2:00 PM and 4:00 PM CST by Avisi Scientific Advisors Dr. Jonathan S. Myers, Dr. Eydie Miller-Ellis, and Dr. Joseph Panarelli.
Avisi retweeted
Avisi Technologies is attending the American Academy of Ophthalmology Annual Meeting in New Orleans, LA, USA, from Oct. 10-12. Visit us at booth #1255 to learn more about VisiPlateĀ®.
Avisi Technologies is attending the American Academy of Ophthalmology Annual Meeting in New Orleans, LA, USA, from Oct. 10-12. Visit us at booth #1255 to learn more about VisiPlateĀ®.
Avisi retweeted
Happy Mid-Autumn Festival! We hope this season brings peace and joy for you and your loved ones.







